Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections | Zendy

Michael D. Parkins | Zendy; Deana Sabuda | Zendy; Sameer Elsayed | Zendy; Kevin B. Laupland | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections

Author(s) -

Michael D. Parkins,

Deana Sabuda,

Sameer Elsayed,

Kevin B. Laupland

Publication year - 2007

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkm212

Subject(s) - odds ratio , medicine , intensive care unit , confidence interval , candida glabrata , population , fungemia , logistic regression , candida albicans , mortality rate , mycosis , intensive care medicine , surgery , antifungal , biology , microbiology and biotechnology , environmental health , dermatology

Although inadequate antimicrobial therapy has been demonstrated in multiple studies to increase the risk for death in bacterial infections, few data investigating the effect of antifungal therapy on outcome of serious fungal disease are available. We sought to assess the adequacy of empirical therapy and its effect on mortality in invasive Candida species infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research